- Exchanges
- BSE, NSE
- Issue
- Book building
Advanced Enzyme Technologies IPO
₹1,178.10
+31.48% on listing
Listing-day close · NSE · 1 Aug 2016 · issue price ₹896
Advanced Enzyme Technologies’ ₹411 crore IPO was priced at ₹896 a share. It listed on the NSE on 1 Aug 2016 and closed its first day at ₹1,178.10, up 31.48% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Listing
Issue details
- Issue size
- ₹411 Cr
- Fresh issue
- ₹50.19 Cr
- Offer for sale
- ₹361 Cr
- Lot size
- 16 shares
- Minimum investment
- ₹14,336
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 81.54× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹2,000 Cr
- Promoter holding
- 63.11% → 49.52%
From the offer documents.
Listing
- Listing date
- 1 Aug 2016
- Issue price
- ₹896
- Open
- ₹1,210.00
- High
- ₹1,244.00
- Low
- ₹1,168.00
- Close
- ₹1,178.10
Listing day on the NSE. The close was +31.48% on the issue price.
ADVENZYMES share price todayFAQs
When did the Advanced Enzyme Technologies IPO open and close?
It opened on 20 Jul 2016 and closed on 22 Jul 2016.
What was the Advanced Enzyme Technologies IPO price?
The price band was ₹880–896 a share. The final issue price was ₹896.
What is the lot size and minimum investment?
One lot is 16 shares, ₹14,336 at ₹896 a share. Retail investors apply in whole lots.
How much did Advanced Enzyme Technologies raise?
₹411 crore: ₹50.19 crore of new shares and ₹361 crore offered by existing shareholders.
How many times was the Advanced Enzyme Technologies IPO subscribed?
81.54 times overall.
How did Advanced Enzyme Technologies list?
It listed on the NSE on 1 Aug 2016 at ₹1,210.00 and closed the day at ₹1,178.10, up 31.48% on the ₹896 issue price.
Who is the registrar of the Advanced Enzyme Technologies IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app